Pepvise
Explainer· Evidence

TB-500 for recovery, what the thymosin beta-4 evidence supports

By The PepVise Editorial Team · Reviewed August 6, 2026 · 8 min read

TB-500 for recovery on the evidence: the animal wound-healing and cardiac-repair data behind thymosin beta-4, the single completed human trial in a different tissue, and why athletic-recovery claims remain unproven.

Mechanism explainers on PepVise aim for textbook-level clarity without the textbook's refusal to commit to a reading.
Frequently asked

What readers ask us next.

Does TB-500 help muscle recovery?
There is no completed human trial testing TB-500 for muscle or training recovery, so a benefit is not established. Recovery claims extrapolate from animal wound-healing and cardiac-repair studies of the parent peptide thymosin beta-4, which is a different context from injected fragment use for athletic recovery.
Is there any human evidence for thymosin beta-4?
The strongest human data is a randomized Phase 2 trial of a thymosin beta-4 eye drop for dry eye (Sosne 2015). It is well-designed but tests a topical eye formulation for an eye condition, which does not validate injected TB-500 for musculoskeletal recovery.
Is TB-500 banned in sport?
Yes. Thymosin beta-4 and related growth factors are prohibited under the World Anti-Doping Agency framework, so athletes subject to testing risk sanctions. This is independent of whether any recovery benefit exists.
Is TB-500 safe to use?
Its long-term human safety is not characterized. There is no completed safety trial for the recovery use case, and research-grade material carries purity and sterility risks. Absence of documented harm is not the same as demonstrated safety.
The sources

References cited on this page.

PubMed, ClinicalTrials.gov, and FDA documents only. Secondary sources appear when needed to characterize public discourse, never as a source for a clinical claim.

  1. [01]Malinda KM et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol 1999
  2. [02]Bock-Marquette I et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004
  3. [03]Goldstein AL et al. Thymosin beta4: a multi-functional regenerative peptide. Expert Opin Biol Ther 2012
  4. [04]Sosne G et al. Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial. Clin Ophthalmol 2015
The masthead

About The Pepvise Editorial Team

The Pepvise Editorial Team is a small group of researchers and science writers reading the peer-reviewed peptide literature and translating it into calm, cited analysis. We do not sell peptides, recommend peptides, or tell readers what to administer. We describe what has been measured, by whom, at what scale, with what effect size.

Compound reviews are signed off by Dr. Priya Narang, MD, MPH (endocrinologist) and Dr. Marcus Haley, PharmD, BCPS (board-certified clinical pharmacist). Both hold verifiable state-board licenses and have signed editorial-independence letters with us. See the full editorial board →

Further reading

Adjacent in the literature.

Evidence · Comparison

GHK-Cu Topical vs Injection: Where the Evidence Sits

GHK-Cu topical versus injection on the evidence: why nearly all the human-relevant data is topical, why injectable use has no trial and raises copper-safety questions, and how to read the two routes honestly.

8 min readEvidence · Explainer

GHK-Cu Before and After: What to Expect From the Evidence

GHK-Cu before-and-after on the evidence: what the skin and hair studies actually measured, why online transformation photos are not trial data, and a realistic view of the timeframes and magnitudes involved.

7 min readEvidence · Explainer

Peptides for Healing: What the Evidence Actually Supports

Peptides for healing on the evidence: which repair-associated peptides have human data, which rest on animal wound-healing models, and why the strongest healing peptide is one most people already know.

9 min read

Get the 2026 Peptide Evidence Ledger.

A 12-page PDF summary of where 10 major compounds sit, Preclinical / Human pilot / Phase trial / FDA status. Updated quarterly. Free.

By subscribing, you agree to our Privacy Policy. One calm, cited email a week. Unsubscribe anytime.